Bli medlem
Bli medlem

Du är här


Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day

est Healthcare Access Day

GAITHERSBURG, Md., 2016-05-11 22:05 CEST (GLOBE NEWSWIRE) --
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the
discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, today announced management will participate in the 2016
Citi Midwest Healthcare Access Day.

Conference details are as follows:

Date: Wednesday, May 18, 2016
Location: Chicago, IL

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation
for ground-breaking innovation that improves global health through safe and
effective vaccines. Additional information about Novavax is available on the
company's website,

Contact: Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.